Karin Meyer becomes new CEO of Center for Translational Research Sweden AB (CTR)

CTR announces that the Board of Directors has appointed Karin Meyer as new Ceo. Karin Meyer succeeds Mats Lindquist, who has been Ceo since the start of CTR 2016.

Karin Meyer has extensive experience of leading positions in the pharmaceutical and biotech industry, good industry knowledge and a very good understanding of the development of new products in these areas. Karin, who is a phD pharmacist, will take up her position as CEO of CTR on 1 May and will then be most recently from the CEO position at Apotekarsocieteten.